达沙替尼联合化疗治疗儿童Ph阳性急性淋巴细胞白血病的疗效及安全性
Efficacy and safety of tyrosine kinase inhibitor dasatinib plus chemotherapy in the treatment of childhood Philadelphia chromosome–positive acute lymphoblastic leukemia

DOI: 10.7499/j.issn.1008-8830.2015.06.021

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text